WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its President and CEO, Dr. Paul Ashton, will present an update on pSivida at the 14th Annual BioCEO & Investor Conference, being held at the Waldorf-Astoria Hotel in New York, Monday and Tuesday, February 13 and 14. Dr. Ashton will make his presentation on Tuesday, February 14 at 2 p.m. EST. A webcast of the presentation will be available at:
http://www.veracast.com/webcasts/bio/ceoinvestor2012/13212311.cfm or at the company’s website: www.psivida.com.
http://www.veracast.com/webcasts/bio/ceoinvestor2012/13212311.cfm or at the company’s website: www.psivida.com.
